Active
Indapta Technologies, Inc
United States
www.google.com/search?q=Indapta%20Technologies%2C%20Inc%20startupIndapta Technologies, Inc is a series a startup based in United States. 2 investors tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
Indapta Therapeutics is harnessing the unique power of Vδ1 gamma-delta (Vδ1) T cells to develop novel allogeneic cell therapies for the treatment of cancer. The company is focused on overcoming the challenges of current cell therapies by utilizing the inherent properties of Vδ1 T cells to create potent, allogeneic, off-the-shelf cell therapies for a wide range of cancers.
Stage
series-a
Investors
2
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky